FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

8159311000001101: Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
20905301000001110 Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
39247701000001113 Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Product containing precisely atazanavir (as atazanavir sulfate) 100 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has excipient Propylene glycol false Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Atazanavir sulfate false Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has active ingredient Atazanavir false Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has excipient Lactose false Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Reyataz true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Atazanavir true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has specific active ingredient Atazanavir sulfate true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Has basis of strength substance Atazanavir true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) 60 capsule 10 x 6 capsules Is pack of False Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier
Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) 60 capsule 10 x 6 capsules Has AMP True Reyataz 100mg capsules (Bristol-Myers Squibb Pharmaceuticals Limited) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start